Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9367)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aravalli RN. Role of innate immunity in the development of hepatocellular carcinoma. World J Gastroenterol 2013; 19(43): 7500-7514 [PMID: 24282342 DOI: 10.3748/wjg.v19.i43.7500] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i43/7500.htm |
| Number | Citing Articles |
| 1 |
Baohui Zhang, Bufu Tang, Jiarui Lv, Jianyao Gao, Ling Qin. Systematic analyses to explore immune gene sets-based signature in hepatocellular carcinoma, in which IGF2BP3 contributes to tumor progression. Clinical Immunology 2022; 241: 109073 doi: 10.1016/j.clim.2022.109073
|
| 2 |
Rui Zhang, Catherine I. Real, Chao Liu, Hideo A. Baba, Guido Gerken, Mengji Lu, Ruth Broering. Hepatic expression of oncogenes Bmi1 and Dkk1 is up‐regulated in hepatitis B virus surface antigen–transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro. International Journal of Cancer 2017; 141(2): 354 doi: 10.1002/ijc.30742
|
| 3 |
An Immortalized Hepatocyte-like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV. Viruses 2019; 11(10): 952 doi: 10.3390/v11100952
|
| 4 |
Jorge André Gomes Lopes, Marta Borges-Canha, Pedro Pimentel-Nunes. Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?. World Journal of Hepatology 2016; 8(3): 162-182 doi: 10.4254/wjh.v8.i3.162
|
| 5 |
Pei-Hao Wen, Dong-Yu Wang, Jia-Kai Zhang, Zhi-Hui Wang, Jie Pan, Xiao-Yi Shi, Han Yang, Shui-Jun Zhang, Wen-Zhi Guo. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo. International Journal of Immunopathology and Pharmacology 2016; 29(4): 666 doi: 10.1177/0394632016655171
|
| 6 |
Chenhao Yao, Shu Dai, Cheng Wang, Ke Fu, Rui Wu, Xingtao Zhao, Yuxin Yao, Yunxia Li. Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies. Biomedicine & Pharmacotherapy 2023; 167: 115464 doi: 10.1016/j.biopha.2023.115464
|
| 7 |
Yiqiong Jia, Zhen Zeng, Yuanyuan Li, Zhiwei Li, Lei Jin, Zheng Zhang, Lifeng Wang, Fu-Sheng Wang, Xue-feng Bai. Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression. PLOS ONE 2015; 10(2): e0117458 doi: 10.1371/journal.pone.0117458
|
| 8 |
Daniela Gabbia, Sara De Martin. Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(4): 3441 doi: 10.3390/ijms24043441
|
| 9 |
Sara de la Fuente, María-Jesús Citores, José-Luis Lucena, Pablo Muñoz, Valentín Cuervas-Mons. TLR9-1486C/T polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation. Biomarkers in Medicine 2019; 13(12): 995 doi: 10.2217/bmm-2019-0030
|
| 10 |
Fabiola Milosa, Rosina Maria Critelli, Simone Lasagni, Alessandra Pivetti, Lorenza Di Marco, Dante Romagnoli, Lucia Carulli, Francesco Dituri, Serena Mancarella, Gianluigi Giannelli, Maria‐Luz Martinez‐Chantar, Luca Fabris, Erica Villa. Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma. Liver Cancer International 2021; 2(1): 15 doi: 10.1002/lci2.23
|
| 11 |
Tomislav Kelava, Petra Turcic, Antonio Markotic, Ana Ostojic, Dino Sisl, Anna Mrzljak. Importance of genetic polymorphisms in liver transplantation outcomes. World Journal of Gastroenterology 2020; 26(12): 1273-1285 doi: 10.3748/wjg.v26.i12.1273
|
| 12 |
Naoki Asano, Akira Imatani, Tomohiro Watanabe, Jun Fushiya, Yutaka Kondo, Xiaoyi Jin, Nobuyuki Ara, Kaname Uno, Katsunori Iijima, Tomoyuki Koike, Warren Strober, Tooru Shimosegawa. Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses. Cancer Research 2016; 76(5): 1135 doi: 10.1158/0008-5472.CAN-15-2272
|
| 13 |
Jingjing Yao, Zhenhua Du, Zibo Li, Shuhui Zhang, Yukun Lin, Haiyun Li, Lin Zhou, Yuehua Wang, Guixi Yan, Xianchuang Wu, Yongjian Duan, Gangjun Du. 6-Gingerol as an arginase inhibitor prevents urethane-induced lung carcinogenesis by reprogramming tumor supporting M2 macrophages to M1 phenotype. Food & Function 2018; 9(9): 4611 doi: 10.1039/C8FO01147H
|
| 14 |
Syed Aun Muhammad, Sidra Zafar, Samana Zahra Rizvi, Imran Imran, Fahad Munir, Muhammad Babar Jamshed, Amjad Ali, Xiaogang Wu, Numan Shahid, Muhammad Zaeem, Qiyu Zhang. Experimental analysis of T cell epitopes for designing liver cancer vaccine predicted by system-level immunoinformatics approach. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(6): G1055 doi: 10.1152/ajpgi.00068.2020
|
| 15 |
Aitor Esparza-Baquer, Ibone Labiano, Omar Sharif, Aloña Agirre-Lizaso, Fiona Oakley, Pedro M Rodrigues, Ekaterina Zhuravleva, Colm J O'Rourke, Elizabeth Hijona, Raul Jimenez-Agüero, Ioana Riaño, Ana Landa, Adelaida La Casta, Marco Y W Zaki, Patricia Munoz-Garrido, Mikel Azkargorta, Felix Elortza, Andrea Vogel, Gernot Schabbauer, Patricia Aspichueta, Jesper B Andersen, Sylvia Knapp, Derek A Mann, Luis Bujanda, Jesus Maria Banales, Maria Jesus Perugorria. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms. Gut 2021; 70(7): 1345 doi: 10.1136/gutjnl-2019-319227
|
| 16 |
Fanqin Bu, Han Nie, Xiaojian Zhu, Ting Wu, Kang Lin, Jiefeng Zhao, Jun Huang. A signature of 18 immune‐related gene pairs to predict the prognosis of pancreatic cancer patients. Immunity, Inflammation and Disease 2020; 8(4): 713 doi: 10.1002/iid3.363
|
| 17 |
Linsen Ye, Yang Li, Hui Tang, Wei Liu, Yunhao Chen, Tianxing Dai, Rongpu Liang, Mengchen Shi, Shuhong Yi, Guihua Chen, Yang Yang. CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis. Aging 2019; 11(20): 8879 doi: 10.18632/aging.102308
|
| 18 |
Perla Chami, Youssef Diab, Danny N. Khalil, Hassan Azhari, William R. Jarnagin, Ghassan K. Abou-Alfa, James J. Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj. Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(23): 16773 doi: 10.3390/ijms242316773
|
| 19 |
Jinhee Hyun, Robert S. McMahon, Anna L. Lang, Jasmine S. Edwards, Alejandro Dmitar Badilla, Morgan E. Greene, Geoffrey W. Stone, Suresh Pallikkuth, Mario Stevenson, Derek M. Dykxhoorn, Shyam Kottilil, Savita Pahwa, Emmanuel Thomas, Daniel C. Douek. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells. PLOS Pathogens 2019; 15(7): e1007883 doi: 10.1371/journal.ppat.1007883
|
| 20 |
Tahany A. Abdel-Raouf, Alaa Ahmed, Wafaa K. Zaki, Heba M. Abdella, Mona Abo Zid. Study of toll-like receptor 7 expression and interferon α in Egyptian patients with chronic hepatitis C Infection and Hepatocellular Carcinoma. Egyptian Journal of Medical Human Genetics 2014; 15(4): 387 doi: 10.1016/j.ejmhg.2014.07.003
|
| 21 |
Su Jong Yu, Tim F. Greten. Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of Liver Cancer 2020; 20(1): 1 doi: 10.17998/jlc.20.1.1
|
| 22 |
Konstantinos Arvanitakis, Triantafyllia Koletsa, Ioannis Mitroulis, Georgios Germanidis. Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers 2022; 14(1): 226 doi: 10.3390/cancers14010226
|
| 23 |
Chean Leong, Hiroyuki Oshiumi, Takayuki Suzuki, Misako Matsumoto, Tsukasa Seya. Nucleic Acid Sensors Involved in the Recognition of HBV in the Liver–Specific in vivo Transfection Mouse Models—Pattern Recognition Receptors and Sensors for HBV. Medical Sciences 2015; 3(2): 16 doi: 10.3390/medsci3020016
|
| 24 |
Lili Li, Rongrong Xie, Guangrong Lu. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Bioscience Reports 2021; 41(6) doi: 10.1042/BSR20210760
|
| 25 |
Kai-Wen Huang, Po-Huang Lee, Tomokazu Kusano, Isabella Reccia, Kumar Jayant, Nagy Habib. Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and disease-free survival. Oncotarget 2017; 8(55): 93644 doi: 10.18632/oncotarget.21271
|
| 26 |
Mathias Gehrmann, Melchiorre Cervello, Giuseppe Montalto, Francesco Cappello, Alessandro Gulino, Clemens Knape, Hanno M. Specht, Gabriele Multhoff. Heat Shock Protein 70 Serum Levels Differ Significantly in Patients with Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00307
|
| 27 |
Meenakshi Sachdeva, Yogesh K Chawla, Sunil K Arora. Immunology of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(17): 2080-2090 doi: 10.4254/wjh.v7.i17.2080
|
| 28 |
Xin Yue, Xin Jiang, Hongjiu Zou, Gaokai Li, Jinan Wang, Ying Liu. Association of hepatocellular carcinoma risk with polymorphisms in tumour necrosis factor alpha gene in a Chinese Han population. International Journal of Immunogenetics 2020; 47(3): 286 doi: 10.1111/iji.12474
|
| 29 |
Ying-Zhe Luo, Hong Zhu. Immunotherapy for advanced or recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(3): 405-424 doi: 10.4251/wjgo.v15.i3.405
Abstract(243) |
Core Tip(215) |
Full Article(HTML)(1713)
|
Full Article (PDF)-3180K(119)
|
Full Article (Word)-369K(33)
|
Audio-500K(6)
|
Peer-Review Report-238K(22)
|
Answering Reviewers-259K(24)
|
Times Cited (0)
|
Total Visits (3874)
|
Open
|
| 30 |
Hui Wang, Ci Song, Qi Qi, Tongtong Huang, Lijuan Wang, Jianguo Chen, Jian Zhu, Zhibin Hu, Juncheng Dai. Functional Polymorphisms in IRAKs Are Related to Hepatocellular Carcinoma Risk in Chinese Population. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/1252849
|
| 31 |
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
|
| 32 |
Fang Wang, Qi Long, Yu Gong, Longbo Hu, Hong Zhang, Peter Oettgen, Tao Peng. Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells. Cell & Bioscience 2014; 4(1) doi: 10.1186/2045-3701-4-76
|
| 33 |
Vahdat Poortahmasebi, Seyed Moayed Alavian, Mohsen Nasiri-Toosi, Mehdi Norouzi, Mostafa Hosseini, Seyed Mohammad Jazayeri. Transcriptome analysis of peripheral blood mononuclear cells from chronic hepatitis B and hepatocellular carcinoma patients: a network-based attitude. Future Virology 2017; 12(12): 729 doi: 10.2217/fvl-2017-0087
|
| 34 |
Xiao‐Yan Sun, Shi‐Zhe Yu, Hua‐Peng Zhang, Jie Li, Wen‐Zhi Guo, Shui‐Jun Zhang. A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma. Cancer Medicine 2020; 9(8): 2868 doi: 10.1002/cam4.2921
|
| 35 |
Helena Degroote, Sander Lefere, Astrid Vandierendonck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher. Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models. Oncotarget 2021; 12(6): 562 doi: 10.18632/oncotarget.27906
|
| 36 |
I-Ting Chen, An-Chieh Cheng, Yi-Ting Liu, Chieh Yan, Yi-Chen Cheng, Chiung-Fang Chang, Ping-Hui Tseng. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA. International Journal of Molecular Sciences 2022; 23(15): 8419 doi: 10.3390/ijms23158419
|
| 37 |
Rajagopal Aravalli, Clifford Steer. Immune-Mediated Therapies for Liver Cancer. Genes 2017; 8(2): 76 doi: 10.3390/genes8020076
|
| 38 |
H. Degroote, A. Van Dierendonck, A. Geerts, H. Van Vlierberghe, L. Devisscher. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7819520
|
| 39 |
Srikanta Dash, Srinivas Chava, Yucel Aydin, Partha Chandra, Pauline Ferraris, Weina Chen, Luis Balart, Tong Wu, Robert Garry. Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response. Viruses 2016; 8(5): 150 doi: 10.3390/v8050150
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_5-1
|
| 41 |
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang, Bin Wu. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1079495
|
| 42 |
Jie Song, Yedan Liu, Ya Guo, Peipei Liu, Fei Li, Chengqing Yang, Xiaoyu Pan, Liping Yi, Fan Fan, Han Zhao, Zongbo Chen. Association of the IRAK4 rs4251545 genetic polymorphism with severity of enterovirus‐71 infection in Chinese children. Immunity, Inflammation and Disease 2022; 10(5) doi: 10.1002/iid3.614
|
| 43 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 121 doi: 10.1007/978-3-319-26956-6_5
|
| 44 |
Erika Ramos-Tovar, Erika Hernández-Aquino, Sael Casas-Grajales, Laura D. Buendia-Montaño, Silvia Galindo-Gómez, Javier Camacho, Víctor Tsutsumi, Pablo Muriel. Stevia Prevents Acute and Chronic Liver Injury Induced by Carbon Tetrachloride by Blocking Oxidative Stress through Nrf2 Upregulation. Oxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/3823426
|